Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study.
Therap Adv Gastroenterol. 2023 May 30;16:17562848231177153. doi: 10.1177/17562848231177153. eCollection 2023.
Therap Adv Gastroenterol. 2023.
PMID: 37274300
Free PMC article.
Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy.
Fiorino G, Colombel JF, Katsanos K, Mearin F, Stein J, Andretta M, Antonacci S, Arenare L, Citraro R, Dell'Orco S, Degli Esposti L, Ramirez de Arellano Serna A, Morin NT, Koutroubakis IE.
Fiorino G, et al. Among authors: arenare l.
Eur J Gastroenterol Hepatol. 2024 May 1;36(5):563-570. doi: 10.1097/MEG.0000000000002740. Epub 2024 Mar 1.
Eur J Gastroenterol Hepatol. 2024.
PMID: 38477856
Free PMC article.
Item in Clipboard
Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic.
Lubrano R, Del Giudice E, Marcellino A, Ventriglia F, Dilillo A, De Luca E, Mallardo S, Isoldi S, Martucci V, Sanseviero M, Iorfida D, Malvaso C, Cerimoniale G, Ragni G, Grandinetti AL, Arenare L, Bloise S.
Lubrano R, et al. Among authors: arenare l.
Children (Basel). 2021 Dec 15;8(12):1183. doi: 10.3390/children8121183.
Children (Basel). 2021.
PMID: 34943379
Free PMC article.
Item in Clipboard
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia.
Perrone V, Giacomini E, Andretta M, Arenare L, Cillo MR, Latini M, Mecozzi A, Pagliaro R, Vercellone A, Degli Esposti L.
Perrone V, et al. Among authors: arenare l.
Ther Clin Risk Manag. 2021 Jun 8;17:617-622. doi: 10.2147/TCRM.S309342. eCollection 2021.
Ther Clin Risk Manag. 2021.
PMID: 34135589
Free PMC article.
Item in Clipboard
Cite
Cite